What is Wolfe Research's price target for MLTX?

Wolfe Research's latest stated price target for MoonLake Immunotherapeutics (MLTX) is $24, from its action on Mar 23, 2026.

What is Wolfe Research's rating on MLTX?

Wolfe Research rates MLTX Outperform, a bullish rating, as of Mar 23, 2026.

When did Wolfe Research last change its view on MLTX?

On Mar 23, 2026, Wolfe Research upgrades to Outperform from Underperform, price target $24.

Analyst firms · Wolfe Research · MLTX

Wolfe Research MLTX price target and rating history

MoonLake Immunotherapeutics (MLTX) · Health Care

Wolfe Research rates MoonLake Immunotherapeutics (MLTX) Outperform with a $24 price target, as of its latest action on Mar 23, 2026. It has published 5 rating actions on MLTX since February 2024, including 2 upgrades and 2 downgrades. Across 5 firms with a MLTX price target in the last 12 months, the median target is $24. Wolfe Research's target matches it.

Current rating: Outperform
Price target: $24
Median target, all firms: $24
Actions on MLTX: 5

Wolfe Research price target on MLTX

Wolfe Research price target on MLTX, each point a stated target, February 2024 to March 2026.

Every Wolfe Research rating on MLTX

Mar 23, 2026
UpgradeWolfe Research upgrades to Outperform from Underperform, price target $24
Sep 30, 2025
DowngradeWolfe Research downgrades to Underperform from Outperform, price target $2
May 19, 2025
UpgradeWolfe Research upgrades to Outperform from Peer Perform, price target $61
Aug 26, 2024
DowngradeWolfe Research downgrades to Peer Perform from Outperform
Feb 15, 2024
InitiateWolfe Research starts coverage at Outperform, price target $77

How other firms rate MLTX

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Chardan Capital Markets	Buy	$57	Nov 6, 2026
Wolfe Research	Outperform	$24	Mar 23, 2026
Rothschild & Co Redburn	Buy	$40	Mar 19, 2026
Goldman Sachs	Sell	$10	Jan 15, 2026
BTIG	Buy	$24	Jan 9, 2026

Questions about Wolfe Research and MLTX

What is Wolfe Research's price target for MLTX?: Wolfe Research's latest stated price target for MoonLake Immunotherapeutics (MLTX) is $24, from its action on Mar 23, 2026.
What is Wolfe Research's rating on MLTX?: Wolfe Research rates MLTX Outperform, a bullish rating, as of Mar 23, 2026.
When did Wolfe Research last change its view on MLTX?: On Mar 23, 2026, Wolfe Research upgrades to Outperform from Underperform, price target $24.
How does Wolfe Research's MLTX target compare with other analysts?: Across 5 firms with a MLTX price target in the last 12 months, the median target is $24. Wolfe Research's target matches it.

More MLTX rating histories

All Wolfe Research ratings MLTX news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.